Cite
MLA Citation
Taiga Nishihori et al.. “An open‐label phase I/II study of cyclophosphamide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed myeloma.” European journal of haematology, vol. 95, n.d., pp. 426–435. http://access.bl.uk/ark:/81055/vdc_100026676944.0x000059